Intensive Surveillance After Stage II or III Colorectal Cancer: Is It Worth It?
- 20 January 2006
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (3) , 330-331
- https://doi.org/10.1200/jco.2005.03.8323
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Postoperative Surveillance in Patients With Colorectal Cancer Who Have Undergone Curative Resection: A Prospective, Multicenter, Randomized, Controlled TrialJournal of Clinical Oncology, 2006
- ErratumJournal of Clinical Oncology, 2005
- Surveillance Strategies after Curative Treatment of Colorectal CancerNew England Journal of Medicine, 2004
- A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal CancerJournal of Clinical Oncology, 2004
- Analysis of Surgical Salvage After Failure of Primary Therapy in Rectal Cancer: Results From Intergroup Study 0114Journal of Clinical Oncology, 2003
- Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal CancerAnnals of Surgery, 1999
- Recommended Colorectal Cancer Surveillance Guidelines by the American Society of Clinical OncologyJournal of Clinical Oncology, 1999
- Surgery for Recurrent Colon Cancer: Strategies for Identifying Resectable Recurrence and Success Rates after ResectionAnnals of Internal Medicine, 1998